Pupillometric analysis for assessment of gene therapy in Leber Congenital Amaurosis patients

BioMedical Engineering Online

Volumn 11, Issue , 2012, Pages

  Melillo, Paolo ^a,b   Pecchia, Leandro ^c   Testa, Francesco ^a   Rossi, Settimio ^a   Bennett, Jean ^d,e   Simonelli, Francesca ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; MATLAB- SOFTWARE; NON-PARAMETRIC; OBJECTIVE INFORMATION; OBJECTIVE MEASURE; OCULAR DISEASE; PUPIL DETECTION; PUPIL IMAGES; PUPILLOMETRY; REFLEX PATHWAY; SEMI-AUTOMATICS; THERAPEUTIC EFFECTS; VISUAL FUNCTIONS; VISUAL IMPAIRMENT; VISUALLY IMPAIRED;

GENE THERAPY; HOUGH TRANSFORMS; LIFE CYCLE; MATLAB; PARAMETER ESTIMATION; STATISTICAL TESTS;

PATIENT TREATMENT;

ADULT; ARTICLE; CLINICAL TRIAL (TOPIC); FEMALE; GENE THERAPY; GENETICS; HUMAN; LEBER CONGENITAL AMAUROSIS; MALE; METHODOLOGY; NEUROLOGIC EXAMINATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PUPIL; REFLEX; TIME; TREATMENT OUTCOME;

ADULT; CLINICAL TRIALS AS TOPIC; FEMALE; GENETIC THERAPY; HUMANS; LEBER CONGENITAL AMAUROSIS; MALE; NEUROLOGIC EXAMINATION; PUPIL; REFLEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84871240339     PISSN: None     EISSN: 1475925X     Source Type: Journal    
DOI: 10.1186/1475-925X-11-40     Document Type: Article

References (34)

1. Stone EM. Leber congenital amaurosis - a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson memorial lecture. Am J Ophthalmol 2007, 144:791-811. 10.1016/j.ajo.2007.08.022, 17964524.
2. Banin E, Bandah-Rozenfeld D, Obolensky A, Cideciyan AV, Aleman TS, Marks-Ohana D, Sela M, Boye S, Sumaroka A, Roman AJ, et al. Molecular anthropology meets genetic medicine to treat blindness in the North African Jewish population: human gene therapy initiated in Israel. Hum Gene Ther 2010, 21:1749-1757. 10.1089/hum.2010.047, 20604683.
3. Hauswirth WW, Aleman TS, Kaushal S, Cideciyan AV, Schwartz SB, Wang L, Conlon TJ, Boye SL, Flotte TR, Byrne BJ, Jacobson SG. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther 2008, 19:979-990. 10.1089/hum.2008.107, 2940541, 18774912.
4. Artur VC. Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy. Prog Retin Eye Res 2010, 29:398-427. 10.1016/j.preteyeres.2010.04.002, 2903652, 20399883.
5. Bennett J, Ashtari M, Wellman J, Marshall KA, Cyckowski LL, Chung DC, McCague S, Pierce EA, Chen Y, Bennicelli JL, et al. AAV2 gene therapy readministration in three adults with congenital blindness. Sci Transl Med 2012, 4:120ra115.
6. Maguire AM, High KA, Auricchio A, Wright JF, Pierce EA, Testa F, Mingozzi F, Bennicelli JL, Ying GS, Rossi S, et al. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet 2009, 374:1597-1605. 10.1016/S0140-6736(09)61836-5, 19854499.
7. Simonelli F, Maguire AM, Testa F, Pierce EA, Mingozzi F, Bennicelli JL, Rossi S, Marshall K, Banfi S, Surace EM, et al. Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol Ther 2010, 18:643-650. 10.1038/mt.2009.277, 2839440, 19953081.
8. Maguire AM, Simonelli F, Pierce EA, Pugh EN, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 2008, 358:2240-2248. 10.1056/NEJMoa0802315, 2829748, 18441370.
9. Fazzi E, Signorini SG, Scelsa B, Bova SM, Lanzi G. Leber's congenital amaurosis: an update. Eur J Paediatr Neurol 2003, 7:13-22. 10.1016/S1090-3798(02)00135-6, 12615170.
10. Aleman TS, Jacobson SG, Chico JD, Scott ML, Cheung AY, Windsor EA, Furushima M, Redmond TM, Bennett J, Palczewski K, Cideciyan AV. Impairment of the transient pupillary light reflex in Rpe65(-/-) mice and humans with leber congenital amaurosis. Invest Ophthalmol Vis Sci 2004, 45:1259-1271. 10.1167/iovs.03-1230, 15037595.
11. Cideciyan AV, Hauswirth WW, Aleman TS, Kaushal S, Schwartz SB, Boye SL, Windsor EA, Conlon TJ, Sumaroka A, Pang JJ, et al. Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year. Hum Gene Ther 2009, 20:999-1004. 10.1089/hum.2009.086, 2829287, 19583479.
12. Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, Viswanathan A, Holder GE, Stockman A, Tyler N, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 2008, 358:2231-2239. 10.1056/NEJMoa0802268, 18441371.
13. Foster RG. Keeping an eye on the time: the Cogan lecture. Invest Ophthalmol Vis Sci 2002, 43:1286-1298.
14. Aleman T, Scott M, Chen R, Chico J, Cheung A, Van Hooser J, Redmond T, Palczewski K, Jacobson S, Cideciyan A. Impairment of the pupillary light reflex in Rpe65-/- mice and patients with leber congenital amaurosis. Invest Ophthalmol Vis Sci 2002, 43:3490.
15. Bergamin O, Zimmerman MB, Kardon RH. Pupil light reflex in normal and diseased eyes: diagnosis of visual dysfunction using waveform partitioning. Ophthalmology 2003, 110:106-114. 10.1016/S0161-6420(02)01445-8, 12511354.
16. Kardon R, Kawasaki A, Miller NR. Origin of the relative afferent pupillary defect in optic tract lesions. Ophthalmology 2006, 113:1345-1353. 10.1016/j.ophtha.2006.02.055, 16877073.
17. Volpe NJ, Dadvand L, Kim SK, Maguire MG, Ying G-S, Moster ML, Galetta SL. Computerized binocular pupillography of the swinging flashlight test detects afferent pupillary defects. Curr Eye Res 2009, 34:606-613. 10.1080/02713680902993891, 19899974.
18. Soille P. Morphological image analysis: principles and applications 1999, Berlin: Springer.
19. Canver MC, Canver AC, Revere KE, Amado D, Bennett J, Chung DC. Algorithm for pupillometric data analysis. Bioengineering conference, proceedings of the 2010 IEEE 36th Annual Northeast; 26-28 March 2010 2010, 1-2. New York: IEEE, Samul K.
20. Kawasaki A, Moore P, Kardon RH. Variability of the relative afferent pupillary defect. Am J Ophthalmol 1995, 120:622-633.
21. Dutsch M, Marthol H, Michelson G, Neundorfer B, Hilz MJ. Pupillography refines the diagnosis of diabetic autonomic neuropathy. J Neurol Sci 2004, 222:75-81. 10.1016/j.jns.2004.04.008, 15240199.
22. Ferrari G, Marques J, Gandhi R, Heller S, Schneider F, Tesfaye S, Gamba H. Using dynamic pupillometry as a simple screening tool to detect autonomic neuropathy in patients with diabetes: a pilot study. Biomed Eng Online 2010, 9:26. 10.1186/1475-925X-9-26, 2893537, 20565794.
23. Smith SA, Dewhirst RR. A simple diagnostic test for pupillary abnormality in diabetic autonomic neuropathy. Diabet Med 1986, 3:38-41. 10.1111/j.1464-5491.1986.tb00703.x, 2951133.
24. Smith SA, Smith SE. Reduced pupillary light reflexes in diabetic autonomic neuropathy. Diabetologia 1983, 24:330-332.
25. Cideciyan AV, Aleman TS, Boye SL, Schwartz SB, Kaushal S, Roman AJ, Pang JJ, Sumaroka A, Windsor EA, Wilson JM, et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. ProcNatlAcad Sci U S A 2008, 105:15112-15117.
26. Cideciyan AV. Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy. Prog Retin Eye Res 2010, 29:398-427. 10.1016/j.preteyeres.2010.04.002, 2903652, 20399883.
27. Kawasaki A, Munier FL, Leon L, Kardon RH. Pupillometric quantification of residual rod and cone activity in patients with visual loss due to Leber congenital amaurosis [abstract]. Acta Ophthalmol 2011, 89:s248.
28. Zhu D, Moore ST, Raphan T. Robust pupil center detection using a curvature algorithm. Comput Methods Prog Biomed 1999, 59:145-157.
29. Iskander DR, Collins MJ, Mioschek S, Trunk M. Automatic pupillometry from digital images. IEEE Trans Biomed Eng 2004, 51:1619-1627. 10.1109/TBME.2004.827546, 15376510.
30. Fotiou F, Fountoulakis KN, Goulas A, Alexopoulos L, Palikaras A. Automated standardized pupillometry with optical method for purposes of clinical practice and research. Clin Physiol 2000, 20:336-347. 10.1046/j.1365-2281.2000.00259.x, 10971544.
31. Melillo P, Bracale M, Pecchia L. Nonlinear heart rate variability features for real-life stress detection. Case study: students under stress due to university examination. Biomed Eng Online 2011, 10:96. 10.1186/1475-925X-10-96, 3305918, 22059697.
32. Melillo P, Fusco R, Sansone M, Bracale M, Pecchia L. Discrimination power of long-term heart rate variability measures for chronic heart failure detection. Med Biol Eng Comput 2011, 49:67-74. 10.1007/s11517-010-0728-5, 21203855.
33. Pecchia L, Melillo P, Sansone M, Bracale M. Discrimination power of short-term heart rate variability measures for CHF assessment. IEEE Trans Inf Technol Biomed 2011, 15:40-46.
34. Pecchia L, Melillo P, Bracale M. Remote health monitoring of heart failure with data mining via CART method on HRV features. IEEE Trans Biomed Eng 2011, 58:800-804.